Korean J Med > Volume 74(5); 2008 > Article
The Korean Journal of Medicine 2008;74(5):481-490.
Clinical characteristics and the risk factors for rebleeding in patients with bleeding peptic ulcer
Jin Woo Choi, Nayoung Kim, Ho June Song, Hyung Min Kang, Ji Youn Yoo, Dong Hun Lee, Chang Kyu Choi, Young Soo Park, Jin-Hyeok Hwang, Jin-Wook Kim, Sook Hyang Jung, Dong
고려대 안산병원 호흡기내과1, 고려대 안산병원 병리과2, 고려대 안산병원 흉부외과3
원저 : 소화성 궤양 출혈 환자의 임상상 및 재출혈 위험인자
최진우, 김나영, 송호준, 강형민, 유지연, 이동훈, 창규, 박영수, 황진혁, 김진욱, 정숙향, 이동호
Abstract
Background/Aims : Bleeding is a serious complication of peptic ulcer. Although endoscopic therapy is effective for achieving hemostasis of active bleeding, rebleeding occurs in 10~30% of these patients. Recently, treatment with proton pump inhibitor (PPI) after hemostasis has decreased the rate of rebleeding. In this study, we analyzed risk factors of peptic ulcer rebleeding and we evaluated whether the rebleeding rate could be different depending on the PPI treatment method. Methods : From March 2003 through February 2006, 639 patients visited the emergency room (ER) due to gastrointestinal hemorrhage. Among them, 191 patients were diagnosed to have peptic ulcer by endoscopy, and they were retrospectively analyzed for their clinical, laboratory and endoscopic findings. The PPI treatment method was categorized into the IV bolus group, the 8 mg/hr continuous infusion group and the others group. Results : Emergency endoscopy was performed within 24 hours in 86.9% of the patients with bleeding peptic ulcer. Rebleeding occurred in 9 cases (4.7%) within 7 days after hemostasis. On the basis of univariate analysis, shock on ER arrival (p=0.013) and over 5 units of packed red cells (PRCs) transfusion (p=0.016) were significant risk factors for rebleeding, yet the PPI treatment method did not affect the rate of rebleeding. Conclusions : The rebleeding rate of peptic ulcer in our study was 4.7%, and this was lower than the previous reports, and the rebleeding rate in our report may have been caused by the early hemostatic therapy together with intravenous infusion of PPI. These approaches are necessary as soon as the patients are stabilized, and especially for the group of patients who are at a high risk for rebleeding, such as those who experience shock at the ER and those who need over 5 units of PRC transfusion.
Key Words: Peptic ulcer; Rebleeding; Risk factor; Proton pump inhibitor


TOOLS
METRICS Graph View
  • 1,424 View
  • 12 Download

Editorial Office
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6791    Fax: +82-2-790-0993    E-mail: kaim@kams.or.kr                

Copyright © 2024 by The Korean Association of Internal Medicine.

Developed in M2PI

Close layer
prev next